Schwarz Pharma Ltd.
49Patents
4Active
49Granted
39Portfolio score
Filing activity: Dec 21, 1988 → Oct 31, 2007 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5393529A | Estrogen-containing active substance plaster | Human Necessities | 114 | Expired |
| US5648096A | Process for the production of microcapsules | Human Necessities | 82 | Expired |
| US5043280A | Method and apparatus for the manufacture of a product having a substance embedded in a carrier | Performing Operations; Transporting | 78 | Expired |
| US5929196A | Polyesters of a polyhydroxycarboxylic acid and a polyol having a substituent with electrolyte properties | Chemistry; Metallurgy | 73 | Expired |
| US6555131B1 | Therapeutical system for transdermal delivery of levonorgestrel | Human Necessities | 58 | Expired |
| US5472710A | Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture | Human Necessities | 57 | Expired |
| US6461636B1 | Transdermal therapeutic system containing pergolide | Human Necessities | 56 | Expired |
| US6562367B1 | Transdermal therapeutic system (TTS) for administering sexual steroid hormones | Human Necessities | 54 | Expired |
| US5370862A | Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina | Human Necessities | 51 | Expired |
| US6783769B1 | Transdermal therapeutic system TTS containing tolterodine | Human Necessities | 38 | Expired |
| US5424076A | Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances | Emerging Cross-Sectional Technologies | 32 | Expired |
| US7309497B2 | Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients | Human Necessities | 30 | Expired |
| US5527536A | Active ingredient patch for low-melting and/or volatile active ingredients | Human Necessities | 27 | Expired |
| US6858650B1 | Stable salts of novel derivatives of 3,3-diphenylpropylamines | Chemistry; Metallurgy | 26 | Expired |
| US5807895A | Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents | Human Necessities | 25 | Expired |
| US7413747B2 | Transdermal therapeutic system for treating Parkinsonism | Human Necessities | 22 | Active |
| US5453283A | Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation | Human Necessities | 21 | Expired |
| US5873860A | Injection device | Human Necessities | 20 | Expired |
| US6248355A | Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation | Human Necessities | 19 | Expired |
| US6803481B2 | Use of peptide class of compound for treating non neuropathic inflammatory pain | Human Necessities | 19 | Expired |
| US6713464B1 | Derivatives of 3,3-diphenylpropylamines | Chemistry; Metallurgy | 18 | Expired |
| US6103769A | Pharmaceutical composition containing nitric oxide | Physics | 16 | Expired |
| US7416864B2 | Method for treating dyskinesia | Human Necessities | 14 | Expired |
| US6207198A | Composition containing an acid-labile omeprazole and process for its preparation | Human Necessities | 14 | Expired |
| US5744124A | Nitroglycerin-containing hydrophilic aqueous pumpable spray composition | Human Necessities | 13 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.